Clinical Trial Update: Blinded Randomized Trial of Anticoagulation to Prevent Ischemic Stroke and Neurocognitive Impairment in AF [Phase 3]

View source ↗

Summary

A Phase 3 blinded randomized trial evaluating anticoagulation to prevent ischemic stroke and neurocognitive impairment in atrial fibrillation has been terminate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Montreal Heart Institute | Conditions: ATRIAL FIBRILLATION | Phase 3 | Status: TERMINATED